What is the most likely diagnosis for a patient presenting with loss of appetite, bloating, abdominal pain, moderate ascites, pleural effusion, bilateral ovarian masses, and an elevated Cancer Antigen 125 (CA 125) level?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 27, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Epithelial Ovarian Tumor

The most likely diagnosis is epithelial ovarian tumor (Option C), specifically advanced-stage disease given the constellation of bilateral ovarian masses, ascites, pleural effusion, and elevated CA-125.

Clinical Presentation Matches Advanced Epithelial Ovarian Cancer

The patient's presentation is classic for advanced epithelial ovarian carcinoma (EOC):

  • Symptoms of bloating, abdominal pain, and loss of appetite are the most frequent presenting complaints in advanced EOC 1
  • Ascites and abdominal distension occur in advanced stage disease when peritoneal metastases are present 1
  • Pleural effusion causing respiratory symptoms indicates stage IV disease with extension into pleural cavities 1
  • Bilateral ovarian masses are characteristic of epithelial ovarian cancer, particularly high-grade serous carcinoma 1

CA-125 Elevation Strongly Supports Epithelial Origin

The CA-125 level of 95 U/mL is diagnostically significant:

  • CA-125 is elevated in approximately 85% of patients with advanced epithelial ovarian cancer 1, 2
  • CA-125 is the primary tumor marker for epithelial ovarian cancer, particularly serous carcinomas which account for 70% of epithelial cases 2
  • While CA-125 can be elevated in benign conditions (endometriosis, ovarian cysts), the combination with bilateral masses, ascites, and pleural effusion makes malignancy far more likely 1, 2

Why Other Options Are Less Likely

Sex cord stromal tumors (Option A) are much less common and typically present differently:

  • These tumors can cause Meigs' syndrome (benign ovarian fibroma with ascites and pleural effusion) 3, 4, 5
  • However, Meigs' syndrome typically involves unilateral or bilateral fibromas/fibrothecomas, not the bilateral malignant-appearing masses described 4, 5
  • While CA-125 can be markedly elevated in Meigs' syndrome, this is a diagnosis of exclusion only after ruling out epithelial ovarian cancer 6

Ovarian germ cell tumors (Option B) are unlikely because:

  • These occur predominantly in younger women and would typically have elevated AFP and β-hCG, not primarily CA-125 7
  • The clinical presentation doesn't match typical germ cell tumor patterns

Gonadoblastoma (Option D) is extremely rare and:

  • Occurs almost exclusively in patients with gonadal dysgenesis
  • Would not present with this clinical picture

Critical Diagnostic Pitfall to Avoid

Do not assume Meigs' syndrome based on elevated CA-125 alone. While benign sex cord stromal tumors can present with ascites, pleural effusion, and markedly elevated CA-125 (even >1000 U/mL), this mimics malignant ovarian cancer and epithelial carcinoma must be ruled out first 3, 4, 5, 8, 6. The bilateral nature of the masses and advanced presentation strongly favor epithelial malignancy over benign stromal tumors.

Next Steps in Management

According to current guidelines, this patient requires:

  • CT imaging of thorax, abdomen, and pelvis to complete staging 1
  • Surgical exploration with comprehensive staging and intraoperative frozen section 7
  • Pathological examination of adequate tumor tissue for definitive diagnosis and molecular testing 1
  • If mucinous histology is suspected, measure CEA and CA 19-9 to distinguish primary ovarian from gastrointestinal metastasis 1, 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Cancers Associated with Elevated CA-125 Levels

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Ovarian mass, pleural effusion, and ascites: revisiting Meigs syndrome.

Journal of bronchology & interventional pulmonology, 2013

Guideline

Surgical Exploration for Ovarian Carcinoma

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.